4.7 Article

Neuroprotectin/Protectin D1 Protects against Neuropathic Pain in Mice after Nerve Trauma

Journal

ANNALS OF NEUROLOGY
Volume 74, Issue 3, Pages 490-495

Publisher

WILEY-BLACKWELL
DOI: 10.1002/ana.23928

Keywords

-

Funding

  1. NIH [R01DE17794, R01DE22743, P01GM095467, R21NS082985, R01NS67686]

Ask authors/readers for more resources

Prevalence of neuropathic pain is high after major surgery. However, effective treatment for preventing neuropathic pain is lacking. Here we report that perisurgical treatment of neuroprotectin D1/protectin D1 (NPD1/PD1), derived from docosahexaenoic acid, prevents nerve injury-induced mechanical allodynia and ongoing pain in mice. Intrathecal post-treatment of NPD1/PD1 also effectively reduces established neuropathic pain and produces no apparent signs of analgesic tolerance. Mechanistically, NPD1/PD1 treatment blocks nerve injury-induced long-term potentiation, glial reaction, and inflammatory responses, and reverses synaptic plasticity in the spinal cord. Thus, NPD1/PD1 and related mimetics might serve as a new class of analgesics for preventing and treating neuropathic pain. Ann Neurol 2013;74:490-495

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available